Endovascular Aneurysm Repair without Procedural Sedation

Letter to Editor
As many trials have demonstrated, endovascular aneurysm repair (EVAR) is an effective method to repair abdominal aortic aneurysms (AAAs). Although AAAs had previously been treated via open surgical repair, EVAR is associated with improved 30-day outcomes, similar long-term outcomes, and dramatically shorter recovery times. [1, 2] EVARs have traditionally been performed under general anesthesia in order to minimize patients' movements during the operation and optimize the precision of graft deployment. Within the last two decades, a number of studies have demonstrated that monitored anesthesia care in EVAR produces similar success and complication rates but lower hospital-stay time compared to general anesthesia. [3] [4] [5] [6] We intend to present a case of a percutaneous EVAR with local anesthesia only and without procedural sedation. Our patient is a 91-year-old male with a past medical history significant for AAA, Grade II diastolic heart failure, paroxysmal atrial fibrillation (only on aspirin given a history of gastrointestinal bleeding), chronic obstructive pulmonary disease, essential hypertension, prediabetes, and chronic cholecystitis status post recent placement of a cholecystostomy tube. The patient had also been recently treated for community-acquired pneumonia with cefpodoxime.
He presented to the emergency department with severe abdominal pain and was found to have an enlarging infrarenal AAA, measuring approximately 6.5 cm [ Figure 1 ]. Given the patient's age and multiple comorbidities, he was deemed a poor candidate for open surgical repair, EVAR under general anesthesia, and EVAR with procedural sedation. We typically use intravenous versed and fentanyl for our percutaneous EVARs. However, given his multiple comorbidities and recent illnesses, we attempted to avoid using any sedative medications in this patient.
Generous subcutaneous injection of 1% lidocaine solution was performed at the entry under ultrasound guidance over the anterior surface of the common femoral arteries [ Figure 2 ]. Bilateral arteriotomies were preclosed using two Perclose ProGlide ® (Abbott, Abbott Park, IL, USA). A 16 Fr GORE ® Dry Seal sheath (W. L. Gore and Associates, Inc. Flagstaff, AZ, USA) was placed in the left common femoral artery after serial fascial dilation, and a 12 Fr sheath was placed in the right common femoral artery. The main body GORE EXCLUDER ® Endoprosthesis (W. L. Gore and Associates, Inc.) was advanced via the left 16 Fr sheath and deployed under fluoroscopic guidance. The GORE EXCLUDER (W. L. Gore and Associates, Inc.) contralateral limb was advanced into position via the 12 Fr sheath and deployed under fluoroscopic guidance, followed by the GORE EXCLUDER ipsilateral limb (W. L. Gore and Associates, Inc.) in similar fashion via the 16 Fr sheath [ Figure 3 ]. Post deployed aortogram was performed. Evidence of endoleak was observed, and repeated molding of the proximal aortic graft and the overlapping segments was performed. Repeat aortography was performed demonstrating improved proximal and distal seal [ Figure 4 ]. At the end of the case, all catheters and wires were removed. Throughout the case, a condom catheter was used to avoid the use of a Foley catheter. Immediate hemostasis was obtained in both groins using standard preclose techniques. The estimated blood loss was <10 cc.
There were no postoperative complications, and the patient's abdominal pain resolved. The patient was able to ambulate, urinate, and resume his diet. His renal function remained stable with adequate urine output. He was discharged the following day in stable condition and had close postoperative follow-up at 2 weeks, 3 months, 6 months, 12 months, and 18 months. The patient continued to remain asymptomatic from his EVAR without need for further interventions.
Percutaneous EVAR without procedural sedation is not suitable for every patient given variations in patient pain tolerance and the complexity unique to every case. However, this case serves as a reminder that performing an EVAR without procedural sedation can be considered when age or comorbidities obviate the possibility of EVAR with general anesthesia or procedural sedation.
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